Reduced serum miR‐202 may promote the progression of Alzheimer's disease patients via targeting amyloid precursor protein
Abstract The current study investigated whether the expression of miR‐202 was abnormal in the serum of patients with Alzheimer's disease (AD) and evaluated the potential clinical significance, thereby shedding light on the diagnosis of AD. Here, our data showed that the level of miR‐202 decreas...
Main Authors: | Li‐Hua Dong, Lei Sun, Wen‐Jing Zhang, Xiao‐Yan Wang, Jia‐Mei Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-08-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | https://doi.org/10.1002/kjm2.12391 |
Similar Items
-
miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway
by: Wei Sun, et al.
Published: (2018-12-01) -
miR-450-5p and miR-202-5p Synergistically Regulate Follicle Development in Black Goat
by: Guanghang Feng, et al.
Published: (2022-12-01) -
Alzheimer-specific variants in the 3'UTR of Amyloid precursor protein affect microRNA function
by: Calon Frédéric, et al.
Published: (2011-10-01) -
Increased Expression of miR-202-3p in Patients with Relapsing-Remitting Multiple Sclerosis
by: Majid Amini Khorasgani, et al.
Published: (2018-12-01) -
An in silico approach to identify potential downstream targets of miR-153 involved in Alzheimer’s disease
by: Sanila Amber, et al.
Published: (2024-01-01)